{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:40:47Z","timestamp":1778226047250,"version":"3.51.4"},"reference-count":37,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003975","name":"Israel Cancer Association","doi-asserted-by":"publisher","award":["20181272"],"award-info":[{"award-number":["20181272"]}],"id":[{"id":"10.13039\/501100003975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001634","name":"Gateway for Cancer Research","doi-asserted-by":"publisher","award":["G17-100"],"award-info":[{"award-number":["G17-100"]}],"id":[{"id":"10.13039\/100001634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,2,8]]},"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pancreatic cancer is characterised by severe mid-back and epigastric pain caused by tumour invasion of the coeliac nerve plexus. This pain is often poorly managed with standard treatments. This clinical trial investigates a novel approach in which high-dose radiation (radiosurgery) is targeted to the retroperitoneal coeliac plexus nerve bundle. Preliminary results from a single institution pilot trial are promising: pain relief is substantial and side effects minimal. The goals of this study are to validate these findings in an international multisetting, and investigate the impact on quality of life and functional status among patients with terminal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>A single-arm prospective phase II clinical trial. Eligible patients are required to have severe coeliac pain of at least five on the 11-point BPI average pain scale and Eastern Cooperative Oncology Group performance status of two or better. Non-pancreatic cancers invading the coeliac plexus are also eligible. The intervention involves irradiating the coeliac plexus using a single fraction of 25 Gy. The primary endpoint is the complete or partial pain response at 3 weeks. Secondary endpoints include pain at 6 weeks, analgesic use, hope, qualitative of life, caregiver burden and functional outcomes, all measured using validated instruments. The protocol is expected to open at a number of cancer centres across the globe, and a quality assurance programme is included. The protocol requires that 90 evaluable patients\" be accrued, based upon the assumption that a third of patients are non-evaluable (e.g. due to death prior to 3-weeks post-treatment assessment, or spontaneous improvement of pain pre-treatment), it is estimated that a total of 120 patients will need to be accrued. Supported by Gateway for Cancer Research and the Israel Cancer Association.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethic approval for this study has been obtained at eight academic medical centres located across the Middle East, North America and Europe. Results will be disseminated through conference presentations and peer-reviewed publications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03323489\">NCT03323489<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-050169","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T04:25:23Z","timestamp":1666585523000},"page":"e050169","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Coeliac plexus radiosurgery for pain management in patients with advanced cancer : study protocol for a phase II clinical trial"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct03323489","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02356406","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1862-1468","authenticated-orcid":false,"given":"Galia","family":"Jacobson","sequence":"first","affiliation":[{"name":"Radiation Oncology, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel"},{"name":"Radiation Oncology, MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronen","family":"Fluss","sequence":"additional","affiliation":[{"name":"Gertner Institute, Sheba Mediacal Center, Tel Hashomer, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira","family":"Dany-BenShushan","sequence":"additional","affiliation":[{"name":"Israeli Center for Cardiovascular Research, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talia","family":"Golan","sequence":"additional","affiliation":[{"name":"Oncology, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel"},{"name":"Sackler School of Medicine, Tel aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tikva","family":"Meron","sequence":"additional","affiliation":[{"name":"Oncology, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4889-0244","authenticated-orcid":false,"given":"Camilla","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network and Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A","family":"Dawson","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Princess Margaret Hospital Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisling","family":"Barry","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Princess Margaret Hospital Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4375-0827","authenticated-orcid":false,"given":"Marcin","family":"Miszczyk","sequence":"additional","affiliation":[{"name":"IIIrd Radiotherapy and Chemotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Buckstein","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayssy","family":"Diaz Pardo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Ohio State University Medical Center, Columbus, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artur","family":"Aguiar","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Portuguese Institute of Oncology of Porto, Porto, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liat","family":"Hammer","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel"},{"name":"Radiatin Oncology, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam P","family":"Dicker","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoz","family":"Ben-Ailan","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofir","family":"Morag","sequence":"additional","affiliation":[{"name":"Cancer Pain Unit, Institute of Oncology, Sheba Medical Center, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hausner","sequence":"additional","affiliation":[{"name":"Cancer Center, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zvi","family":"Symon","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel"},{"name":"Sackler School of Medicine, Tel aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9959-2485","authenticated-orcid":false,"given":"Yaacov R.","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel"},{"name":"Sackler School of Medicine, Tel aviv University, Tel Aviv, Israel"},{"name":"Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"2025121409333527000_12.3.e050169.1","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1200\/JCO.1995.13.3.748","article-title":"Pain and depression in patients with newly diagnosed pancreas cancer","volume":"13","author":"Kelsen","year":"1995","journal-title":"J Clin Oncol"},{"key":"2025121409333527000_12.3.e050169.2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.15403\/jgld.2014.1121.252.pcr","article-title":"Pancreatic cancer: multicenter prospective data collection and analysis by the Hungarian pancreatic Study Group","volume":"25","author":"Lakatos","year":"2016","journal-title":"J Gastrointestin Liver Dis"},{"key":"2025121409333527000_12.3.e050169.3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000218355","article-title":"Presentation, treatment, and analysis of prognostic factors of terminally ill patients with gastrointestinal tumors","volume":"32","author":"Gencer","year":"2009","journal-title":"Onkologie"},{"key":"2025121409333527000_12.3.e050169.4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1159\/000201499","article-title":"Prospective evaluation of pain in exocrine pancreatic cancer","volume":"58","author":"Grahm","year":"1997","journal-title":"Digestion"},{"key":"2025121409333527000_12.3.e050169.5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s11764-016-0544-5","article-title":"Pancreatic cancer survivors' preferences, barriers, and facilitators related to physical activity and diet interventions","volume":"10","author":"Arthur","year":"2016","journal-title":"J Cancer Surviv"},{"key":"2025121409333527000_12.3.e050169.6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000098177","article-title":"Health-Related quality of life in patients with pancreatic cancer","volume":"74","author":"M\u00fcller-Nordhorn","year":"2006","journal-title":"Digestion"},{"key":"2025121409333527000_12.3.e050169.7","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21332"},{"key":"2025121409333527000_12.3.e050169.8","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJCA.2018.07.005"},{"key":"2025121409333527000_12.3.e050169.9","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S160018"},{"key":"2025121409333527000_12.3.e050169.10","doi-asserted-by":"crossref","first-page":"ii79","DOI":"10.1093\/annonc\/mdi705","article-title":"How to deal with difficult pain problems","volume":"16 Suppl 2","author":"Cherny","year":"2005","journal-title":"Ann Oncol"},{"key":"2025121409333527000_12.3.e050169.11","doi-asserted-by":"crossref","DOI":"10.4251\/wjgo.v8.i8.599","article-title":"Road map for pain management in pancreatic cancer: a review","volume":"8","author":"Lahoud","year":"2016","journal-title":"World J Gastrointest Oncol"},{"key":"2025121409333527000_12.3.e050169.12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5055\/jom.2016.0309","article-title":"Opioids for outpatients with cancer in their last year of life: a nationwide pharmacoepidemiological study","volume":"12","author":"Brelin","year":"2016","journal-title":"J Opioid Manag"},{"key":"2025121409333527000_12.3.e050169.13","first-page":"CD007519","article-title":"Celiac plexus block for pancreatic cancer pain in adults","volume":"3","author":"Arcidiacono","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121409333527000_12.3.e050169.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(03)70036-4"},{"key":"2025121409333527000_12.3.e050169.15","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.1999.17.8.2419","article-title":"Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer","volume":"17","author":"Zhu","year":"1999","journal-title":"J Clin Oncol"},{"key":"2025121409333527000_12.3.e050169.16","doi-asserted-by":"publisher","DOI":"10.1148\/rg.316115526"},{"key":"2025121409333527000_12.3.e050169.17","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(93)90130-H"},{"key":"2025121409333527000_12.3.e050169.18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.9.1092"},{"key":"2025121409333527000_12.3.e050169.19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gie.2020.01.011","article-title":"Efficacy of EUS-guided celiac plexus neurolysis compared with medication alone for unresectable pancreatic cancer in the oxycodone\/fentanyl era: a prospective randomized control study","volume":"92","author":"Kanno","year":"2020","journal-title":"Gastrointest Endosc"},{"key":"2025121409333527000_12.3.e050169.20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.6.2403"},{"key":"2025121409333527000_12.3.e050169.21","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"Folfirinox versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025121409333527000_12.3.e050169.22","first-page":"3589","article-title":"Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study","volume":"24","author":"Beesley","year":"2016","journal-title":"Support Care Cancer"},{"key":"2025121409333527000_12.3.e050169.23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/082585970301900407","article-title":"Pain relief with short-term irradiation in locally advanced carcinoma of the pancreas","volume":"19","author":"Morganti","year":"2003","journal-title":"J Palliat Care"},{"key":"2025121409333527000_12.3.e050169.24","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3892\/mco.2016.851","article-title":"Tolerance and efficacy of palliative radiotherapy for advanced pancreatic cancer: a retrospective analysis of single-institutional experiences","volume":"4","author":"Wolny-Rokicka","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"2025121409333527000_12.3.e050169.25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/01.coc.0000145290.06582.c3","article-title":"Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas","volume":"28","author":"Wong","year":"2005","journal-title":"Am J Clin Oncol"},{"key":"2025121409333527000_12.3.e050169.26","first-page":"246","article-title":"Dose escalation of concurrent hypofractionated radiotherapy and continuous infusion 5-FU-chemotherapy in advanced adenocarcinoma of the pancreas","volume":"52","author":"Zimmermann","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"2025121409333527000_12.3.e050169.27","doi-asserted-by":"crossref","unstructured":"Lawrence YR , Hammer L , Morag O , et al . Abstract CT147: celiac plexus radiosurgery a new palliative modality for upper gastrointestinal malignancies-final quality of life results from a proof-of-concept clinical trial. AACR, 2019.","DOI":"10.1158\/1538-7445.AM2019-CT147"},{"key":"2025121409333527000_12.3.e050169.28","doi-asserted-by":"publisher","DOI":"10.1197\/aemj.10.4.390"},{"key":"2025121409333527000_12.3.e050169.29","doi-asserted-by":"publisher","DOI":"10.1097\/00002820-199704000-00002"},{"key":"2025121409333527000_12.3.e050169.30","doi-asserted-by":"publisher","DOI":"10.1186\/cc6789"},{"key":"2025121409333527000_12.3.e050169.31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2026.2003.00499.x"},{"key":"2025121409333527000_12.3.e050169.32","doi-asserted-by":"publisher","DOI":"10.1521\/jscp.2009.28.4.479"},{"key":"2025121409333527000_12.3.e050169.33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1089\/jpm.2012.0625","article-title":"Reliability and concurrent validity of the palliative outcome scale, the Rotterdam symptom checklist, and the brief pain inventory","volume":"16","author":"Pelayo-Alvarez","year":"2013","journal-title":"J Palliat Med"},{"key":"2025121409333527000_12.3.e050169.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2007.04.007"},{"key":"2025121409333527000_12.3.e050169.35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020731"},{"key":"2025121409333527000_12.3.e050169.36","doi-asserted-by":"crossref","unstructured":"Cleeland CS , Ryan K . The brief pain inventory. pain Research Group, 1991: 143\u20137.","DOI":"10.1037\/t04175-000"},{"key":"2025121409333527000_12.3.e050169.37","unstructured":"Health UDo, Services H . Common terminology criteria for adverse events (CTCAE) version 4.0. 4. National Institutes of Health, National Cancer Institute, 2009."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-050169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:33:45Z","timestamp":1765733625000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-050169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,24]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1136\/bmjopen-2021-050169"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-050169","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}